TY - JOUR
T1 - Decreased neural inhibitory state in fibromyalgia pain
T2 - A cross-sectional study
AU - Uygur-Kucukseymen, Elif
AU - Castelo-Branco, Luis
AU - Pacheco-Barrios, Kevin
AU - Luna-Cuadros, Maria Alejandra
AU - Cardenas-Rojas, Alejandra
AU - Giannoni-Luza, Stefano
AU - Zeng, Huiyan
AU - Gianlorenco, Anna Carolyna
AU - Gnoatto-Medeiros, Marina
AU - Shaikh, Emad Salman
AU - Caumo, Wolnei
AU - Fregni, Felipe
N1 - Publisher Copyright:
© 2020 Elsevier Masson SAS
PY - 2020/9
Y1 - 2020/9
N2 - Objectives: Chronic pain is one of the most common and challenging symptoms in fibromyalgia (FM). Currently, self-reported pain is the main criterion used by clinicians assessing patients with pain. However, it is subjective, and multiple factors can affect pain levels. In this study, we investigated the neural correlates of FM pain using conditioned pain modulation (CPM), electroencephalography (EEG), and transcranial magnetic stimulation (TMS). Methods: In this cross-sectional neurophysiological analysis of a randomized, double-blind controlled trial, 36 patients with fibromyalgia were included. We analyzed CPM, EEG variables and TMS measures and their correlation with pain levels as measured by a visual analog scale. Univariate and multivariate linear regression analyses were performed to identify the predictors of pain severity. Results: We found: (1) no association between pain levels and CPM; (2) an association between reduced alpha and beta power over the central region in resting-EEG and higher pain levels; (3) an association between smaller event-related desynchronization (ERD) responses in theta and delta bands over the central region and higher pain levels; (4) an association between smaller ERD responses in theta and delta bands and smaller intracortical inhibition and higher intracortical facilitation ratios; (5) an association between smaller ERD responses in delta band and reduced CPM. Conclusions: Our results do not support CPM as a biomarker for pain intensity in FM. However, our specific EEG findings showing the relationship between pain, CPM and TMS measures suggest that FM leads to a disruption of inhibitory neural modulators and thus support CPM as a likely predictive marker of disrupted pain modulation system. These neurophysiological markers need to be further explored in potential future trials as to find novel targets for the treatment of FM.
AB - Objectives: Chronic pain is one of the most common and challenging symptoms in fibromyalgia (FM). Currently, self-reported pain is the main criterion used by clinicians assessing patients with pain. However, it is subjective, and multiple factors can affect pain levels. In this study, we investigated the neural correlates of FM pain using conditioned pain modulation (CPM), electroencephalography (EEG), and transcranial magnetic stimulation (TMS). Methods: In this cross-sectional neurophysiological analysis of a randomized, double-blind controlled trial, 36 patients with fibromyalgia were included. We analyzed CPM, EEG variables and TMS measures and their correlation with pain levels as measured by a visual analog scale. Univariate and multivariate linear regression analyses were performed to identify the predictors of pain severity. Results: We found: (1) no association between pain levels and CPM; (2) an association between reduced alpha and beta power over the central region in resting-EEG and higher pain levels; (3) an association between smaller event-related desynchronization (ERD) responses in theta and delta bands over the central region and higher pain levels; (4) an association between smaller ERD responses in theta and delta bands and smaller intracortical inhibition and higher intracortical facilitation ratios; (5) an association between smaller ERD responses in delta band and reduced CPM. Conclusions: Our results do not support CPM as a biomarker for pain intensity in FM. However, our specific EEG findings showing the relationship between pain, CPM and TMS measures suggest that FM leads to a disruption of inhibitory neural modulators and thus support CPM as a likely predictive marker of disrupted pain modulation system. These neurophysiological markers need to be further explored in potential future trials as to find novel targets for the treatment of FM.
KW - Biomarker
KW - Chronic pain
KW - Conditioned pain modulation
KW - Electroencephalography
KW - Event-related desynchronization
KW - Fibromyalgia
KW - Neural inhibitory state
KW - Transcranial magnetic stimulation
UR - http://www.scopus.com/inward/record.url?scp=85087690005&partnerID=8YFLogxK
U2 - 10.1016/j.neucli.2020.06.002
DO - 10.1016/j.neucli.2020.06.002
M3 - Artículo
C2 - 32654884
AN - SCOPUS:85087690005
SN - 0987-7053
VL - 50
SP - 279
EP - 288
JO - Neurophysiologie Clinique
JF - Neurophysiologie Clinique
IS - 4
ER -